ImmunityBio Inc (NASDAQ: IBRX) kicked off on Tuesday, down -3.26% from the previous trading day, before settling in for the closing price of $2.15. Over the past 52 weeks, IBRX has traded in a range of $1.83-$5.43.
A company in the Healthcare sector has jumped its sales by 2.39% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 27.10%. With a float of $303.30 million, this company’s outstanding shares have now reached $984.97 million.
ImmunityBio Inc (IBRX) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of ImmunityBio Inc is 69.21%, while institutional ownership is 14.61%.
ImmunityBio Inc (IBRX) Latest Financial update
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.08 earnings per share (EPS), higher than consensus estimate (set at -0.13) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.10% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 62.07% during the next five years compared to 2.39% growth over the previous five years of trading.
ImmunityBio Inc (NASDAQ: IBRX) Trading Performance Indicators
Take a look at ImmunityBio Inc’s (IBRX) current performance indicators. Last quarter, stock had a quick ratio of 5.65. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 24.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.42, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.33 in one year’s time.
Technical Analysis of ImmunityBio Inc (IBRX)
Let’s dig in a bit further. During the last 5-days, its volume was 9.23 million. That was better than the volume of 8.36 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 52.87%.
During the past 100 days, ImmunityBio Inc’s (IBRX) raw stochastic average was set at 11.21%, which indicates a significant decrease from 44.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.12 in the past 14 days, which was lower than the 0.14 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.38, while its 200-day Moving Average is $2.64. However, in the short run, ImmunityBio Inc’s stock first resistance to watch stands at $2.16. Second resistance stands at $2.23. The third major resistance level sits at $2.29. If the price goes on to break the first support level at $2.03, it is likely to go to the next support level at $1.97. The third support level lies at $1.90 if the price breaches the second support level.
ImmunityBio Inc (NASDAQ: IBRX) Key Stats
The company with the Market Capitalisation of 2.05 billion has total of 984,965K Shares Outstanding. Its annual sales at the moment are 14,750 K in contrast with the sum of -413,560 K annual income. Company’s last quarter sales were recorded 32,060 K and last quarter income was -67,250 K.
